Indicated for: anemia; catabolic states
Route of administration: ophthalmic
Substance: nandrolone (anabolic steroid)
ATC: S01XA11 (Sensory organs | Other ophthalmologicals)
Nandrolone is an anabolic steroid used for the treatment of anemia, osteoporosis, and other conditions involving muscle mass loss. It stimulates protein synthesis and muscle growth, helping to improve the overall condition of patients.
The medication is administered via intramuscular injection, usually once every few weeks, with the dose adjusted based on the condition being treated. Common side effects include fluid retention, acne, and changes in libido.
Nandrolone is contraindicated in patients with prostate cancer, male breast cancer, or hypersensitivity to the active substance. Long-term use also requires careful monitoring to prevent severe adverse effects.
This medication is an effective option for patients needing increased muscle mass or relief from symptoms associated with anemia and osteoporosis.